What are the major opportunities in the Drug Eluting Stent market? What are the strategies for the Drug Eluting Stent market?

For detailed insights on the major opportunities and strategies in the Drug Eluting Stent market, Read More

How does the Drug Eluting Stent market relate to the overall economy and other similar markets?

For detailed insights on Drug Eluting Stent's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Drug Eluting Stent market growth? SWOT analysis of the Drug Eluting Stent market.

For detailed insights on the key dynamics influencing the Drug Eluting Stent market growth and SWOT analysis of the Drug Eluting Stent industry, Read More

Global Drug Eluting Stent Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report

Drug Eluting Stent Global Market Report 2025

Name: Drug Eluting Stent Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Product (Polymer-Based, Polymer-Free), By Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds), By Application (Coronary Diseases, Peripheral Vascular Diseases), By End-User (Hospitals, Specialty Clinics) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Drug Eluting Stent Market Overview

• Drug Eluting Stent market size has reached to $7.63 billion in 2024

• Expected to grow to $11.07 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%

• Growth Driver: Impact Of Coronary Heart Disease On Drug-Eluting Stent Market

• Market Trend: Innovation In Advanced Drug-Eluting Coronary Stents

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Drug Eluting Stent Market?

A drug-eluting stent (DES) is a medical device used in the treatment of coronary artery disease (CAD). It is a small, mesh-like tube typically made of metal that is inserted into narrowed or blocked coronary arteries during a procedure called percutaneous coronary intervention (PCI) or angioplasty.

The main product types of drug eluting stents are polymer-based and polymer-free. Polymer-based drug-eluting stents (DES) are stents coated with a thin polymer layer that contains the drug(s) to be delivered to the arterial wall. The drug types include sirolimus, paclitaxel, zotarolimus, everolimus, biolimus, others with scaffolds such as cobalt-chromium, platinum-chromium, nitinol, biodegradable, and others used in applications such as coronary diseases and peripheral vascular disease by end-users such as hospitals and specialty clinics.

Drug Eluting Stent Market Size and growth rate 2025 to 2029: Graph

What Is The Drug Eluting Stent Market Size 2025 And Growth Rate?

What Is The Drug Eluting Stent Market Growth Forecast?

The drug eluting stent market size is expected to see strong growth in the next few years. It will grow to $11.07 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to an aging population and chronic disease burden, the expansion of indications, healthcare reimbursement policies, global market expansion, and patient-centered care. Major trends in the forecast period include personalized medicine, minimally invasive techniques, emerging healthcare technologies, and next-generation drug formulations.

The forecast of 7.6% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for biodegradable polymer carriers and cobalt-chromium platforms, sourced from key regions such as Belgium and Singapore, which could lead to delayed coronary interventions and increased prices for life-saving cardiac devices.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How Is The Drug Eluting Stent Market Segmented?

1) By Product: Polymer-Based, Polymer-Free

2) By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs

3) By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds

4) By Application: Coronary Diseases, Peripheral Vascular Diseases

5) By End-User: Hospitals, Specialty Clinic

Subsegments:

1) By Polymer-Based: Durable Polymer Drug-Eluting Stents, Biodegradable Polymer Drug-Eluting Stents

2) By Polymer-Free: Bare-Metal Stents With Drug Coating, Other Polymer-Free Drug-Eluting Stents

What Is Driving The Drug Eluting Stent Market? Impact Of Coronary Heart Disease On Drug-Eluting Stent Market

The rising burden of coronary heart disease is expected to propel the growth of the drug-eluting stent market going forward. Coronary heart disease (CHD) is a condition where the coronary arteries become narrowed or blocked due to plaque buildup, potentially leading to severe complications such as a heart attack or chest pain. Coronary heart disease is increasing due to sedentary lifestyles, poor diets, aging populations, and heightened awareness. Drug-eluting stents (DES) benefit coronary heart disease by effectively opening narrowed or blocked coronary arteries and releasing medication that helps prevent re-narrowing (restenosis) of the artery. For instance, in May 2024, according to the Centers for Disease Control and Prevention, a US-based governmental organization, the percentage of coronary heart disease in adults aged 18 and over in 2020 was 4.6%, which increased to 4.9% in 2022. The rising burden of coronary heart disease is expected to propel the growth of the drug-eluting stench market.

Who Are The Major Players In The Global Drug Eluting Stent Market?

Major companies operating in the drug eluting stent market are Johnson & Johnson Services Inc., Abbott, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, InspireMD Inc., B. Braun Melsungen AG, Cook Group Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Biotronik, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Company Limited, Alvimedica Medical Technologies, Hexacath, Elixir Medical Corporation, Translumina GmbH, Cardionovum GmbH, QualiMed Innovative Medizinprodukte GmbH, InSitu Technologies Inc., Acrostak AG, SINOMED Innovation Inc., Svelte Medical Systems Inc.

What Are The Key Trends Of The Global Drug Eluting Stent Market? Innovation In Advanced Drug-Eluting Coronary Stents

Companies operating in the drug-eluting stent market are focusing on developing innovative delivery systems, such as the dual-layer balloon, to improve patient outcomes and advance the field of interventional cardiology. A dual-layer balloon in a drug-eluting stent system enhances precision in drug delivery and stent deployment by providing better control and uniform drug application to the arterial wall. For instance, in August 2022, Medtronic Plc, an Ireland-based provider of medical supplies, launched Onyx Frontier, the latest generation of drug-eluting coronary stent systems designed to enhance delivery systems that build upon the acute performance and clinical data from the previous generation of Resolute Onyx DES. The Onyx Frontier DES leverages the same best-in-class stent platform as Resolute Onyx, with a broad size matrix to treat patients ranging from 2.0mm to 5.0mm in diameter. The Onyx Frontier DES incorporates notable design enhancements, such as a groundbreaking dual-layer balloon, reduced crossing profile, and improved catheter flexibility. These improvements yield a 16% increase in deliverability over the prior Resolute Onyx DES generation, all while preserving radial strength.

Need data on a specific region in this market?

Request Customisation

What Are Latest Mergers And Acquisitions In The Drug Eluting Stent Market? Expansion Of Cordis' Cardiovascular Portfolio Through MedAlliance Acquisition

In October 2023, Cordis, a US-based developer and manufacturer of interventional vascular medical devices, acquired MedAlliance for an undisclosed amount. The acquisition aims to advance Cordis' legacy of cardiovascular innovation and expand its product portfolio in the coronary and peripheral vascular markets. M.A. Med Alliance SA is a Switzerland-based medical device manufacturer and distributor specializing in drug-eluting stents.

What Is The Regional Outlook For The Global Drug Eluting Stent Market?

North America was the largest region in the drug-eluting stent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Drug Eluting Stent Market?

The drug eluting stent market consists of revenues earned by entities by providing services such as pre-procedural assessment, procedural intervention, intraoperative monitoring, post-procedural care, and patient education. The market value includes the value of related goods sold by the service provider or included within the service offering. The drug eluting stenting market also includes sales of products including guide wires, angioplasty equipment, intravascular imaging systems, hemostasis devices, and diagnostic tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Drug Eluting Stent Industry?

The drug eluting stent market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the drug eluting stent industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Drug Eluting Stent Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$8.26 billion
Revenue Forecast In 2034	$11.07 billion
Growth Rate	CAGR of 7.6% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Product: Polymer-Based, Polymer-Free 2) By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs 3) By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds 4) By Application: Coronary Diseases, Peripheral Vascular Diseases 5) By End-User: Hospitals, Specialty Clinic Subsegments: 1) By Polymer-Based: Durable Polymer Drug-Eluting Stents, Biodegradable Polymer Drug-Eluting Stents 2) By Polymer-Free: Bare-Metal Stents With Drug Coating, Other Polymer-Free Drug-Eluting Stents
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Johnson & Johnson Services Inc., Abbott, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, InspireMD Inc., B. Braun Melsungen AG, Cook Group Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Biotronik, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Company Limited, Alvimedica Medical Technologies, Hexacath, Elixir Medical Corporation, Translumina GmbH, Cardionovum GmbH, QualiMed Innovative Medizinprodukte GmbH, InSitu Technologies Inc., Acrostak AG, SINOMED Innovation Inc., Svelte Medical Systems Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Drug Eluting Stent Market Characteristics

3. Drug Eluting Stent Market Trends And Strategies

4. Drug Eluting Stent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Drug Eluting Stent Growth Analysis And Strategic Analysis Framework

5.1. Global Drug Eluting Stent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Drug Eluting Stent Market Growth Rate Analysis

5.4. Global Drug Eluting Stent Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Drug Eluting Stent Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Drug Eluting Stent Total Addressable Market (TAM)

6. Drug Eluting Stent Market Segmentation

6.1. Global Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Polymer-Based

Polymer-Free

6.2. Global Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sirolimus

Paclitaxel

Zotarolimus

Everolimus

Biolimus

Other Drugs

6.3. Global Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cobalt-Chromium

Platinum-Chromium

Nitinol

Biodegradable

Other Scaffolds

6.4. Global Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Coronary Diseases

Peripheral Vascular Diseases

6.5. Global Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinic

6.6. Global Drug Eluting Stent Market, Sub-Segmentation Of Polymer-Based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Durable Polymer Drug-Eluting Stents

Biodegradable Polymer Drug-Eluting Stents

6.7. Global Drug Eluting Stent Market, Sub-Segmentation Of Polymer-Free, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bare-Metal Stents With Drug Coating

Other Polymer-Free Drug-Eluting Stents

7. Drug Eluting Stent Market Regional And Country Analysis

7.1. Global Drug Eluting Stent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Drug Eluting Stent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Eluting Stent Market

8.1. Asia-Pacific Drug Eluting Stent Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Eluting Stent Market

9.1. China Drug Eluting Stent Market Overview

9.2. China Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Eluting Stent Market

10.1. India Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Eluting Stent Market

11.1. Japan Drug Eluting Stent Market Overview

11.2. Japan Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Eluting Stent Market

12.1. Australia Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Eluting Stent Market

13.1. Indonesia Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Eluting Stent Market

14.1. South Korea Drug Eluting Stent Market Overview

14.2. South Korea Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Eluting Stent Market

15.1. Western Europe Drug Eluting Stent Market Overview

15.2. Western Europe Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Eluting Stent Market

16.1. UK Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Eluting Stent Market

17.1. Germany Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Eluting Stent Market

18.1. France Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Eluting Stent Market

19.1. Italy Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Eluting Stent Market

20.1. Spain Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Eluting Stent Market

21.1. Eastern Europe Drug Eluting Stent Market Overview

21.2. Eastern Europe Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Eluting Stent Market

22.1. Russia Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Eluting Stent Market

23.1. North America Drug Eluting Stent Market Overview

23.2. North America Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Eluting Stent Market

24.1. USA Drug Eluting Stent Market Overview

24.2. USA Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Eluting Stent Market

25.1. Canada Drug Eluting Stent Market Overview

25.2. Canada Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Eluting Stent Market

26.1. South America Drug Eluting Stent Market Overview

26.2. South America Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Eluting Stent Market

27.1. Brazil Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Eluting Stent Market

28.1. Middle East Drug Eluting Stent Market Overview

28.2. Middle East Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Eluting Stent Market

29.1. Africa Drug Eluting Stent Market Overview

29.2. Africa Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Eluting Stent Market Competitive Landscape And Company Profiles

30.1. Drug Eluting Stent Market Competitive Landscape

30.2. Drug Eluting Stent Market Company Profiles

30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Abbott Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Drug Eluting Stent Market Other Major And Innovative Companies

31.1. InspireMD Inc.

31.2. B. Braun Melsungen AG

31.3. Cook Group Incorporated

31.4. Lepu Medical Technology (Beijing) Co. Ltd.

31.5. Biotronik

31.6. Meril Life Sciences Pvt. Ltd.

31.7. MicroPort Scientific Corporation

31.8. Biosensors International Group Ltd.

31.9. OrbusNeich Medical Company Limited

31.10. Alvimedica Medical Technologies

31.11. Hexacath

31.12. Elixir Medical Corporation

31.13. Translumina GmbH

31.14. Cardionovum GmbH

31.15. QualiMed Innovative Medizinprodukte GmbH

32. Global Drug Eluting Stent Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Eluting Stent Market

34. Recent Developments In The Drug Eluting Stent Market

35. Drug Eluting Stent Market High Potential Countries, Segments and Strategies

35.1 Drug Eluting Stent Market In 2029 - Countries Offering Most New Opportunities

35.2 Drug Eluting Stent Market In 2029 - Segments Offering Most New Opportunities

35.3 Drug Eluting Stent Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Drug Eluting Stent Market, Sub-Segmentation Of Polymer-Based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Drug Eluting Stent Market, Sub-Segmentation Of Polymer-Free, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Drug Eluting Stent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Drug Eluting Stent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Johnson & Johnson Services Inc. Financial Performance

Table 79: Abbott Financial Performance

Table 80: Medtronic plc Financial Performance

Table 81: Boston Scientific Corporation Financial Performance

Table 82: Terumo Corporation Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Drug Eluting Stent Market, Sub-Segmentation Of Polymer-Based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Drug Eluting Stent Market, Sub-Segmentation Of Polymer-Free, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Drug Eluting Stent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Drug Eluting Stent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Johnson & Johnson Services Inc. Financial Performance

Figure 79: Abbott Financial Performance

Figure 80: Medtronic plc Financial Performance

Figure 81: Boston Scientific Corporation Financial Performance

Figure 82: Terumo Corporation Financial Performance

Global 3D Bioprinting Market Projected to Reach $5.04 Billion by 2029 at a CAGR of 23.1%

$15.02 Billion Forecast for AI-based Surgical Robots Market by 2029, Backed by Demand and Innovation

Arrhythmia Monitoring Devices Market Forecast Reaching $12.03 Billion by 2029 at 10.2% CAGR

Autoinjectors Market Valuation Expected To Reach $9.93 Billion By 2029, Growing At A Rate Of 21.8%

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical syringe drive systems market backed by expert analysis and data-driven projections.

Toasters Global Market Report 2025 – By Product Type (Pop-Up Toasters, Toaster Ovens, Conveyor Toasters), By Distribution channel (Online, Offline), By End-User (Residential, Commercial) – Impact of Tariff and Trade War ...

View Report

Soft Touch Polyurethane Coatings Global Market Report 2025 – By Base Type( Water-based, Solvent-based), By Product Type( 2K, UV), By End-Use( Automotive, Aerospace, Electrical and Electronic, Furniture, Packaging, Other ...

View Report

Bioabsorbable Stents Global Market Report 2025 – By Product Type (Polymer-based Bioabsorbable Stents, Metal-based Bioabsorbable Stents), By Absorption Rate (Slow- absorption stents, Fast- absorption Stents), By Applicati...

View Report

Feed And Animal Nutrition Global Market Report 2025 – By Product Type (Amino Acids, Vitamins, Minerals, Enzymes, Fish Oils And Nutrition Lipids, Eubiotics, Carotenoids, Other Product Types), By Species (Poultry, Swine, R...

View Report

Sharing Accommodation Global Market Report 2025 – By Product (Economy Type, Comfortable Type, Boutique Type, Luxury Type, Other Products), By Booking Mode (Offline, Online And Platform-Based), By Application (Tourism, Bu...

View Report

Intracranial Stents Global Market Report 2025 – By Type (Self Expanding Stents, Balloon Expanding Stents, Stent-Assisted Coil Embolization), By Disease Indication (Brain Aneurysm, Intracranial Stenosis), By End-User (Hos...

View Report

Aerospace Engineering Services Outsourcing Global Market Report 2025 – By Component (Software, Hardware ), By Service (Design And Engineering, Manufacturing Support, Security And Certification, After-Market Services ), B...

View Report

Frequently Asked Questions

What is the definition of the Drug Eluting Stent market?

How will the Drug Eluting Stent market drivers and restraints affect the market dynamics? What forces will shape the Drug Eluting Stent industry going forward?

The market major growth driver - Impact Of Coronary Heart Disease On Drug-Eluting Stent Market. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Drug Eluting Stent market?

The drug eluting stent market size has grown strongly in recent years. It will grow from $7.63 billion in 2024 to $8.26 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to the need for improved treatment options, clinical evidence, regulatory approval, healthcare economics, and guidelines and recommendations. The drug eluting stent market size is expected to see strong growth in the next few years. It will grow to $11.07 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to an aging population and chronic disease burden, the expansion of indications, healthcare reimbursement policies, global market expansion, and patient-centered care. Major trends in the forecast period include personalized medicine, minimally invasive techniques, emerging healthcare technologies, and next-generation drug formulations. For further insights on this market, request a sample here

How is the Drug Eluting Stent market segmented?

The drug eluting stentmarket covered in this report is segmented –
1) By Product: Polymer-Based, Polymer-Free
2) By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs
3) By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds
4) By Application: Coronary Diseases, Peripheral Vascular Diseases
5) By End-User: Hospitals, Specialty Clinic Subsegments:
1) By Polymer-Based: Durable Polymer Drug-Eluting Stents, Biodegradable Polymer Drug-Eluting Stents
2) By Polymer-Free: Bare-Metal Stents With Drug Coating, Other Polymer-Free Drug-Eluting Stents For further insights on this market, request a sample here

Which region has the largest share of the Drug Eluting Stent market? What are the other regions covered in the report?

North America was the largest region in the drug-eluting stent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Drug Eluting Stent market?

What are the key trends in the Drug Eluting Stent market?

Major trends in this market include Innovation In Advanced Drug-Eluting Coronary Stents. For further insights on this market, request a sample here.

Book your 30 minutes free consultation with our research experts

Drug Eluting Stent Global Market Report 2025

Drug Eluting Stent Market Overview

What Is Covered Under Drug Eluting Stent Market?

What Is The Drug Eluting Stent Market Size 2025 And Growth Rate?

What Is The Drug Eluting Stent Market Growth Forecast?

What’s The Trade War Impact On Medical Equipment Industry?

How Is The Drug Eluting Stent Market Segmented?

What Is Driving The Drug Eluting Stent Market? Impact Of Coronary Heart Disease On Drug-Eluting Stent Market

Who Are The Major Players In The Global Drug Eluting Stent Market?

What Are The Key Trends Of The Global Drug Eluting Stent Market? Innovation In Advanced Drug-Eluting Coronary Stents

What Are Latest Mergers And Acquisitions In The Drug Eluting Stent Market? Expansion Of Cordis' Cardiovascular Portfolio Through MedAlliance Acquisition

What Is The Regional Outlook For The Global Drug Eluting Stent Market?

What Defines the Drug Eluting Stent Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Drug Eluting Stent Industry?

Drug Eluting Stent Market Report Forecast Analysis

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions